Heptares Therapeutics
Jayesh Patel has a diverse work experience in the field of protein engineering and scientific research. Jayesh started their career as a Post-doctoral Associate at Yale University School of Medicine in 2002 and later became an Associate Research Scientist. In 2009, they joined Heptares as a Senior Scientist I and progressed to the role of Senior Scientist II before becoming a Principal Scientist. In 2018, they transitioned to Sosei Heptares as a Principal Scientist and later took on the role of Associate Director. Currently, they serve as the Director of Protein Engineering at Sosei Heptares.
Jayesh Patel's education history includes a Bachelor of Science degree in Biochemistry from Imperial College London. Jayesh later pursued a doctorate in Molecular Cell Biology at UCL. Jayesh also attended Yale University, although the specific details regarding their degree or field of study are not provided.
Heptares Therapeutics
Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, StabilisedReceptors), overcoming a major limiting factor to the development of new drugs targeting this group.